Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-13684

Stopper, H; Walitza, S; Warnke, A; Gerlach, M (2008). Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. Journal of Neural Transmission, 115(2):331-334.

[img] PDF - Registered users only


Children affected by attention deficit/hyperactivity disorder are often treated with methylphenidate (MPH). Two years ago, an increase in genomic damage after 3 months of MPH treatment was reported by researchers from Texas, U.S.A., raising concern about potential carcinogenic effects. In a similar investigation conducted in Wuerzburg, Germany, we did not find a comparable elevation of genomic damage. MPH is not genotoxic in standard test systems, but yielded one positive result in a rodent carcinogenicity study at the highest test dose only (60-fold above therapeutic doses). In conclusion, changes in treatment strategies do not seem justified currently. Larger studies are under way and will hopefully eliminate any remaining doubt about potential genotoxic or carcinogenic consequences of MPH treatment.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Child and Adolescent Psychiatry
DDC:610 Medicine & health
Deposited On:14 Feb 2009 19:03
Last Modified:27 Nov 2013 18:55
Publisher DOI:10.1007/s00702-007-0829-y
PubMed ID:17994183
Citations:Web of Science®. Times Cited: 10
Google Scholar™
Scopus®. Citation Count: 11

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page